{"id":126453,"date":"2024-10-19T05:37:06","date_gmt":"2024-10-19T05:37:06","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-pd-iso-ts-93202024\/"},"modified":"2024-10-24T23:20:12","modified_gmt":"2024-10-24T23:20:12","slug":"bsi-pd-iso-ts-93202024","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-pd-iso-ts-93202024\/","title":{"rendered":"BSI PD ISO\/TS 9320:2024"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms, definitions and abbreviations 3.1 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 3.2 Abbreviated terms 4 Significance of haemodialysis data set 4.1 General <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 4.2 Unique elements in the haemodialysis data set 4.3 Purpose of a standardized data set <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 5 Use case 5.1 General 5.2 Haemodialytic patient with no special problems 5.3 HIV positive haemodialytic patient 5.4 Haemodialytic patient with refractory heart failure <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 6 Data sets for transfer of haemodialysis 6.1 General <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.2 Fields of required data 6.2.1 General 6.2.2 Last dialysis date <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 6.2.3 Haemodialysis interval 6.2.4 Dry weight <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 6.2.5 Haemodialysis machine model 6.2.6 Haemodialysis blood flow rate 6.2.7 Haemodialysis access type <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6.2.8 Haemodialysis access site 6.2.9 Haemodialysis access status <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 6.2.10 Hepatitis type B antigen \/ antibody 6.2.11 Hepatitis C virus infection <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 6.2.12 Human immunodeficiency virus infection 6.2.13 Dialysis duration <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 6.2.14 Dialysate 6.3 Fields of conditionally-required data 6.3.1 General 6.3.2 Initial dialysis date <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 6.3.3 Last laboratory test date 6.3.4 Blood type <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 6.3.5 Diagnosis 6.3.6 Blood haemoglobin concentration <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 6.3.7 Blood sodium concentration 6.3.8 Blood potassium concentration <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 6.3.9 Blood calcium concentration 6.3.10 Blood phosphate concentration <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 6.3.11 Venereal disease research laboratory <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 6.3.12 Pre-dialysis vital sign 6.3.13 Post-dialysis vital sign <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 6.3.14 Interdialytic weight gain 6.3.15 Prescription <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 6.3.16 Remark note 6.4 Fields of optional data 6.4.1 General 6.4.2 Heparin concentration <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 6.4.3 Remnant kidney function 6.4.4 Other laboratory results <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 6.4.5 Radiology report 6.4.6 Allergy <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | 6.4.7 Presence of heart failure 6.4.8 Heart ejection fraction <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | 6.4.9 Haemodialysis access construction date <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Annex A (informative) Example of a haemodialysis referral paper <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex B (informative) Example of an FHIR resource <\/td>\n<\/tr>\n | ||||||
61<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Health informatics. Standardized data set for transfer of hemodialysis patients<\/b><\/p>\n |